US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3309-4 D-1603-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3308-4 D-1602-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3307-4 D-1601-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3305-4 D-1600-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3303-4 D-1599-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3299-4 D-1598-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3302-4 D-1597-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3300-4 D-1596-2020
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason Sub-Potent Drug: Out of specification test results for potency (below specification).

Teva Pharmaceuticals USA NDC 0093-4177-73 D-1566-2020
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Teva Pharmaceuticals USA NDC 0093-4177-73 D-0013-2021
Class II · Moderate risk Terminated

Cephalexin for Oral Suspension

Reason CGMP deviations; there is a possibility that some bottles in these lots may have the active ingredient above and/or below specification limits.

Teva Pharmaceuticals USA NDC 0093-4175-73 D-0012-2021
Class II · Moderate risk Terminated

Zanilast+ Gel Antiseptic Hand Sanitizer

Reason GMP Deviations: Potential to contain 1-propanol.

Nanomateriales Sa De Cv NDC 69912-006-01 D-1593-2020
Class II · Moderate risk Terminated

Zanilast+ Gel Antiseptic Hand Sanitizer

Reason GMP Deviations: Potential to contain 1-propanol.

Nanomateriales Sa De Cv NDC 69912-008-01 D-1592-2020
Class II · Moderate risk Terminated

Buprenorphine HCl Injection

Reason Sub-potent Drug: Out-of-Specification assay results found at 3 month stability testing.

Hikma Pharmaceuticals USA Inc. D-1533-2020
Class II · Moderate risk Terminated

Florance Morris ANTISEPTIC Hand Sanitizer

Reason CGMP Deviations: All other lots are being recalled because they were manufactured under the same conditions as the product lots found to contain methanol.

Grupo Asimex de Mexico SA de CV D-0796-2021
Class II · Moderate risk Terminated

BusPIRone Hydrochloride Tablets

Reason Failed Impurity /Degradation Specifications

Par Pharmaceutical Inc. NDC 49884-725-01 D-1542-2020
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets

Reason Presence of Foreign Substance: product complaints were received by the firm for the presence of metal wire in the tablet(s).

Aurobindo Pharma USA Inc. D-1535-2020
Class II · Moderate risk Terminated

Prednisone Tablets

Reason Labeling: Label Mix Up: bottle labeled to contain Prednisone Tablets, USP 2.5 mg actually contained Prednisone Tablets, USP 10 mg

Lannett Company, Inc. NDC 0527-2931-37 D-1508-2020